Mahamaya Lifesciences
173.00
+1.00(+0.58%)
Market Cap₹404.94 Cr
PE Ratio31.10
IndustryChemicals
Company Performance:
1D+0.58%
1M-0.46%
6M+48.05%
1Y+49.14%
5Y+49.14%
View Company Insightsright
More news about Mahamaya Lifesciences
09Mar 26
Mahamaya Lifesciences Withdraws from Arihant Capital Virtual Conference Due to Scheduling Constraints
Mahamaya Lifesciences Limited has withdrawn from the Arihant Capital Bharat Connect Virtual Conference Rising Star 2026 scheduled for March 9, 2026, due to internal scheduling constraints and business priorities. The company communicated this decision to the Bombay Stock Exchange under SEBI regulations, reversing its earlier commitment made on March 5, 2026. Managing Director Krishnamurthy Ganesan signed the official withdrawal notification to maintain regulatory compliance and transparency with stakeholders.
 no imag found
22Jan 26
Mahamaya Lifesciences Limited Receives 'Company of the Year – Medium Scale' Award at ICSCE 2026, Dubai
Mahamaya Lifesciences Limited received the 'Company of the Year – Medium Scale' award at ICSCE 2026 in Dubai on January 20, 2026, presented by PMFAI. The company disclosed this achievement under SEBI Regulation 30 on January 22, 2026, highlighting its excellence in the pharmaceutical sector and compliance with regulatory requirements.
 no imag found
17Dec 25
Vijay Kedia Acquires 8.91 Lakh Shares in Mahamaya Lifesciences at ₹140 Per Share
Investor Vijay Kedia has purchased 8.91 lakh shares of Mahamaya Lifesciences, an SME-listed agro chemicals company, at ₹140 per share. The total investment amounts to ₹12.47 crores, representing a substantial stake in the small-cap firm. This move has drawn attention to the company and the agro chemicals sector.
 no imag found
02Dec 25
Mahamaya Lifesciences Reports 17.6% Profit Growth in H1 FY26
Mahamaya Lifesciences, a provider of agricultural crop protection solutions, announced unaudited financial results for H1 FY26. Revenue from operations increased by 11.5% to ₹16,306.37 lakhs. Standalone profit rose by 17.6% to ₹852.56 lakhs. Earnings per share improved by 7.1% to ₹4.80. The results were approved by the Board of Directors on December 02, 2025. The company's performance indicates strong market position and increasing demand for its products in the agricultural sector.
 no imag found
Mahamaya Lifesciences
173.00
+1.00
(+0.58%)
1 Year Returns:+49.14%
Industry Peers
UPL
634.35
(+0.17%)
PI Industries
2,901.20
(-7.15%)
Sumitomo Chemical
460.75
(-1.74%)
Bayer Crop Science
4,315.50
(-0.89%)
Sharda Cropchem
890.20
(-2.85%)
Dhanuka Agritech
1,150.80
(-2.61%)
Rallis
247.90
(-2.05%)
NACL Industries
161.71
(-0.44%)
Bharat Rasayan
1,395.70
(-1.32%)